Similarly, low-molecular-weight fucoidan, when combined with an oligonucleotide aptamer (GroA, AS1411), a cell surface Nucleolin inhibitor, significantly improved the anti-proliferative effect of GroA, as it decreased cancer cell growth and viability and increased cell death [241]. The gene discussed is CXCL1; the disease is cancer.